Skip to main content
. 2019 Jun 18;11(6):844. doi: 10.3390/cancers11060844

Table 1.

Revised PTEN hamartoma tumor syndrome (PHTS) diagnostic criteria.

Revised PTEN Hamartoma Tumor Syndrome (PHTS) Clinical Diagnostic Criteria [16,17]
Operational Diagnosis in an Individual (either of the following):
   (1) Three or more major criteria, but one must include macrocephaly, Lhermitte–Duclos disease, or gastrointestinal hamartomas; OR
   (2) Two major and three minor criteria;
Operational Diagnosis in a Family where One Individual Meets Revised PHTS Clinical Diagnostic Criteria or Has a PTEN Mutation:
   (1) Any two major criteria with or without minor criteria; OR
   (2) One major and two minor criteria; OR
   (3) Three minor criteria
Major Criteria
   Breast cancer
   Endometrial cancer (epithelial)
   Thyroid cancer (follicular)
   Gastrointestinal hamartomas (including ganglioneuromas, but excluding hyperplastic polyps) (≥3)
   Lhermitte–Duclos disease (LDD), adult
   Macrocephaly (≥97 percentile)
   Macular pigmentation of the glans penis
   Multiple mucocutaneous lesions (any of the following):
   Multiple trichilemmomas (≥3), at least one biopsy proven
   Acral keratoses (≥3 palmoplantar keratotic pits and/or acral hyperkeratotic papules)
   Mucocutaneous neuromas (≥3)
   Oral papillomas (particularly on tongue and gingiva), multiple (≥3) OR biopsy-proven OR dermatologist-diagnosed
Minor Criteria
   Autism spectrum disorder
   Colon cancer
   Esophageal glycogenic acanthosis (≥3)
   Lipomas (≥3)
   Mental retardation (i.e., Intelligence Quotient (IQ) ≤ 75)
   Renal cell carcinoma
   Testicular lipomatosis
   Thyroid cancer (papillary or follicular variant of papillary)
   Thyroid structural lesions (e.g., adenoma, multinodular goiter)
   Vascular anomalies (including multiple intracranial developmental venous anomalies)